Quantcast

Latest Heart failure Stories

2014-09-17 08:30:11

- Up to $200 Million Collaboration to Support Pioneering Science and New Treatments - PARIS and SOUTH SAN FRANCISCO, Calif., Sept. 17, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and MyoKardia, Inc., a privately-held company leading the development of precision therapies for genetic heart disease, announced today a worldwide collaboration to discover and develop first-of-its-kind targeted therapeutics for heritable heart diseases known as cardiomyopathies, the most...

2014-09-17 08:29:17

Third Multi-Center Study Shows Compelling Results Consistent with Previous Trials; Data Presented at TCT KIRKLAND, Wash., Sept. 17, 2014 /PRNewswire/ -- Cardiac Dimensions(®), Inc. today announced that new long-term outcomes data from the TITAN II clinical trial of its enhanced CARILLON Mitral Contour System showed significant and sustained improvements in mitral regurgitation, functional improvement, quality of life and reverse cardiac remodeling. The long-term safety and efficacy data,...

2014-09-17 08:28:32

ZUG, Switzerland, Sept. 17, 2014 /PRNewswire/ -- Cardiorentis AG, a privately held biopharmaceutical company, today announced that it has entered into a EUR45 million financing agreement with HealthCare Royalty Partners ("HC Royalty"), a U.S. based healthcare investment firm. The proceeds will be used to finance the Company's registration program for the natriuretic peptide Ularitide in acute heart failure. "This is a pivotal time for our Company. The team at HC Royalty understood...

2014-09-16 23:02:05

This family focused event that includes a 5K and 1 mile Run/Walk continues a unique collaboration between the University of Colorado Denver and Children's Hospital Colorado -- both national and world leaders in PH research and patient care. Silver Spring, Md. (PRWEB) September 16, 2014 Who: The Pulmonary Hypertension Association (PHA), The University of Colorado Anschutz Medical Campus and Children’s Hospital Colorado are hosting Colorado PH in the Park 2014. PHA is the country’s...

2014-09-16 12:24:58

Peer-reviewed case report says implantation of the SynCardia Total Artificial Heart restores "normal biventricular circulation" to a congenital patient with only one functioning ventricle. The male patient was bridged to a donor heart 61 days later. TUCSON, Ariz., Sept. 16, 2014 /PRNewswire/ -- Surgeons at The Children's Hospital of Philadelphia describe in a case report the first successful use of a SynCardia temporary Total Artificial Heart (TAH-t) in a 13- year-old boy with failing Fontan...

2014-09-15 12:28:16

Dr. Milton Packer and Dr. McMurray will be presenting these results for the first time in the United States at the HFSA Annual Meeting LAS VEGAS, Sept. 15, 2014 /PRNewswire/ -- The Heart Failure Society of America (HFSA) will host it's 18(th) Annual Scientific Meeting that will feature a late breaking clinical trial which tested an Angiotensin Receptor Neprilysin inhibitor (ARNi) as a potential alternative to Angiotensin converting enzyme (ACE) inhibitors for patients with heart...

2014-09-15 08:29:19

DUBLIN, Sept. 15, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Cardiac POC Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Cardiac POC is a medical test performed near to the site of the patient. The Cardiac POCs are simple medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include Troponin and brain natriuretic peptide tests, which are used to diagnose cardiovascular...

2014-09-14 20:20:15

Analysis From SHIFT Study Shows Ivabradine Reduced Cardiovascular Death or Hospitalization for Worsening Heart Failure Independent of Baseline Blood Pressure With Similar Safety Profile Across Groups THOUSAND OAKS, Calif., Sept. 14, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced data from the Phase 3 SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study evaluating ivabradine in patients with chronic heart failure (HF) were presented at the 18(th)...

2014-09-14 12:21:00

Dr. Gary Francis to receive 2014 Lifetime Achievement Award LAS VEGAS, Sept. 14, 2014 /PRNewswire/ -- The Heart Failure Society of America's (HFSA) 18(th) Annual Scientific Meeting convenes on Sunday, September 14(th), 2014 at the Caesars Palace Hotel in Las Vegas. This four-day meeting--a forum for heart failure specialists to present research findings and advances in treatment--will address emerging trends in research and new developments in the approach to treating patients with all stages...

2014-09-11 23:07:37

St. Elizabeth Health Center received the Get With The Guidelines® -- Heart Failure Gold Quality Achievement Award from the American Heart Association for the third consecutive year. Youngstown, OH (PRWEB) September 11, 2014 St. Elizabeth Health Center has received the Get With The Guidelines® -- Heart Failure Gold Quality Achievement Award from the American Heart Association for the third year in a row. St. Elizabeth Health Center earned the award by meeting stringent quality...


Latest Heart failure Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »
Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'